Reaction
Pneumonia Respiratory Syncytial Viral reporting signals
As of the last recalculation, Pneumonia Respiratory Syncytial Viral appears in 815 FAERS reports alongside 35 co-occurring drug terms. The strongest observed disproportionality signal is PALIVIZUMAB (PRR 151.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Palivizumab | 82 | 151.5 | 152.3 |
| Selinexor | 16 | 48.1 | 48.2 |
| Terbinafine Hydrochloride | 15 | 43.9 | 44.0 |
| Fludarabine Phosphate | 62 | 43.5 | 43.6 |
| Melphalan | 37 | 43.5 | 43.5 |
| Melphalan Hydrochloride | 39 | 41.7 | 41.7 |
| Busulfan | 18 | 29.9 | 29.9 |
| Thiotepa | 11 | 29.8 | 29.8 |
| Valganciclovir | 21 | 29.2 | 29.2 |
| Valganciclovir Hydrochloride | 21 | 29.2 | 29.2 |
| Valganciclovir Hydrochloride Powder, | 13 | 27.6 | 27.7 |
| Daratumumab | 35 | 23.3 | 23.4 |
| Abacavir Sulfate | 8 | 21.2 | 21.2 |
| Sirolimus | 11 | 21.1 | 21.1 |
| Carfilzomib | 22 | 20.4 | 20.4 |
| Azacitidine For | 14 | 20.0 | 20.0 |
| Mesna Injection | 6 | 18.7 | 18.7 |
| Mesna | 6 | 18.3 | 18.3 |
| Axicabtagene Ciloleucel | 7 | 18.3 | 18.3 |
| Bendamustine Hcl | 10 | 16.7 | 16.7 |
| Pomalidomide | 62 | 16.6 | 16.6 |
| Cyclophosphamide Injection, Solution | 89 | 14.3 | 14.3 |
| Cyclophosphamide | 89 | 14.3 | 14.3 |
| Cyclophosphamide For Injection | 89 | 14.3 | 14.3 |
| Fesoterodine Fumarate | 6 | 14.2 | 14.2 |
| Azacitidine | 16 | 14.0 | 14.0 |
| Etoposide | 38 | 13.8 | 13.8 |
| Cytarabine | 31 | 13.7 | 13.7 |
| Fluticasone Furoate And Vilanterol Trifenatate | 17 | 12.3 | 12.3 |
| Bortezomib | 38 | 11.3 | 11.3 |
| Doxorubicin | 36 | 10.7 | 10.8 |
| Polatuzumab Vedotin | 4 | 10.5 | 10.5 |
| Vigabatrin | 4 | 7.0 | 7.0 |
| Lenalidomide | 95 | 6.4 | 6.4 |
| Ixazomib | 7 | 6.3 | 6.3 |